LHDN E-Invoice mandatory data requirements from All Customers.
Kindly update by LHDN Data Requirement Form TODAY!! CLICK here
|
|
Facilities |
All the success Kotra Pharma has reaped over the years stems from our simple philosophy of Humansing Health – Everyone Deserves A Healthier Tomorrow, ensuring that people from all walks of life have the basic right to quality healthcare. Kotra Pharma has made its mission to be the centre of excellence for pharmaceutical industry through its five pillars of excellence.
To support this mission, one such endeavour was our investment in state-of-art manufacturing facilities. With an investment of RM210 million into developing these facilities, the Kotra Pharma Technology Centre (“KPTC”) was fully operational by 2013. KPTC is Good Manufacturing Practice (“GMP”) certified, in accordance to the Pharmaceutical Inspection Convention & Pharmaceutical Co-operation Scheme (“PIC/s”) and was designed using the Quality by Design (“QbD”) concept. With QbD and automated technology, our product quality attributes are built into our manufacturing system. KPTC was also awarded the Industry Excellence Award in 2012 by the National Pharmaceutical Regulatory Agency (“NPRA”).
This modern manufacturing plant and research facility coupled with our team of highly skilled engineers, delivers on our promise to support healthcare needs with consistent delivery of quality pharmaceutical products. The critical manufacturing process equipment are equipped with automated ‘clean in place’ and ‘sterilised in place’ technologies that ensures efficient management of an automated critical cleaning process and sterilisation. The centralised real time monitoring of the entire manufacturing facilities, including its utilities support, are controlled by an intelligent Building Management System (BMS) and Clean Room Manufacturing System (CMS). Besides that, IBC containment bins with patented dust-free transfer valves are used in the manufacturing suites to minimise the possibility of cross contamination and also provide a high level of safe working environment.
The establishment of KPTC is also part of an effort to support the Malaysian market’s growth and to meet the increasing demand of international healthcare needs. As a local pharmaceutical manufacturer, we are committed to drive our Malaysian pharmaceutical industry globally.
All the success Kotra Pharma has reaped over the years stems from our simple philosophy of Humansing Health – Everyone Deserves A Healthier Tomorrow, ensuring that people from all walks of life have the basic right to quality healthcare. Kotra Pharma has made its mission to be the centre of excellence for pharmaceutical industry through its five pillars of excellence.
To support this mission, one such endeavour was our investment in state-of-art manufacturing facilities. With an investment of RM210 million into developing these facilities, the Kotra Pharma Technology Centre (“KPTC”) was fully operational by 2013. KPTC is Good Manufacturing Practice (“GMP”) certified, in accordance to the Pharmaceutical Inspection Convention & Pharmaceutical Co-operation Scheme (“PIC/s”) and was designed using the Quality by Design (“QbD”) concept. With QbD and automated technology, our product quality attributes are built into our manufacturing system. KPTC was also awarded the Industry Excellence Award in 2012 by the National Pharmaceutical Regulatory Agency (“NPRA”).
This modern manufacturing plant and research facility coupled with our team of highly skilled engineers, delivers on our promise to support healthcare needs with consistent delivery of quality pharmaceutical products. The critical manufacturing process equipment are equipped with automated ‘clean in place’ and ‘sterilised in place’ technologies that ensures efficient management of an automated critical cleaning process and sterilisation. The centralised real time monitoring of the entire manufacturing facilities, including its utilities support, are controlled by an intelligent Building Management System (BMS) and Clean Room Manufacturing System (CMS). Besides that, IBC containment bins with patented dust-free transfer valves are used in the manufacturing suites to minimise the possibility of cross contamination and also provide a high level of safe working environment.
The establishment of KPTC is also part of an effort to support the Malaysian market’s growth and to meet the increasing demand of international healthcare needs. As a local pharmaceutical manufacturer, we are committed to drive our Malaysian pharmaceutical industry globally.